Related Experiment Video
Updated: Jul 27, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Arterial stiffness tested by pulse wave velocity and augmentation index for cardiovascular risk stratification in
Gerasimos Evangelatos1,2, George Konstantonis1, Nikolaos Tentolouris1
1First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Insights
Antiphospholipid syndrome (APS) patients show increased arterial stiffness, specifically in augmentation index, compared to healthy individuals. This arterial stiffening, a cardiovascular risk factor, highlights the need for closer monitoring in APS patients.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Vascular Biology
Background:
- Antiphospholipid syndrome (APS) is a significant cause of cardiovascular morbidity and mortality.
- Arterial stiffness (ArS) is a recognized predictor of cardiovascular events in the general population.
Purpose of the Study:
- To evaluate arterial stiffness (ArS) in patients with thrombotic Antiphospholipid syndrome (APS).
- To compare ArS in APS patients against those with diabetes mellitus (DM) and healthy controls (HC).
- To identify predictors of increased ArS within the APS cohort.
Main Methods:
- Arterial stiffness was assessed using carotid-femoral pulse wave velocity (cfPWV) and augmentation index (AIx@75).
- Carotid and femoral ultrasounds were performed to detect atherosclerotic plaques.
- Linear regression models were employed to compare ArS measures and identify determinants in APS patients.
Main Results:
- APS patients exhibited significantly higher AIx@75 compared to HC, indicating enhanced arterial stiffening.
- While cfPWV was similar between APS and HC, APS patients had lower cfPWV than DM patients.
- Independent predictors of increased cfPWV in APS included age, mean arterial pressure (MAP), femoral atherosclerotic plaques, and anti-β2-glycoprotein I IgM positivity.
Conclusions:
- APS patients demonstrate elevated AIx@75, suggesting increased arterial stiffening.
- Arterial stiffness evaluation may improve cardiovascular risk stratification in APS patients.
- The findings underscore the importance of assessing ArS in managing cardiovascular risk in APS.
Objectives:
Cardiovascular disease is a major cause of morbidity and mortality in Antiphospholipid syndrome (APS). Arterial stiffness (ArS) has emerged as a predictor of future cardiovascular events in the general population. We aimed to assess ArS in patients with thrombotic APS versus diabetes mellitus (DM) and healthy controls (HC) and identify predictors of increased ArS in APS.
Methods:
ArS was evaluated by carotid-femoral pulse wave velocity (cfPWV) and augmentation index normalized to 75 beats/min (AIx@75) using the SphygmoCor device. Participants also underwent carotid/femoral ultrasound for atherosclerotic plaque detection. We used linear regression to compare ArS measures among groups and assess ArS determinants in the APS group.
Results:
We included 110 patients with APS (70.9% female, mean age 45.4 years), 110 DM patients and 110 HC, all age/sex matched. After adjustment for age, sex, cardiovascular risk factors and plaque presence, APS patients exhibited similar cfPWV [β = -0.142 (95% CI -0.514, 0.230), p = 0.454] but increased AIx@75 [β = 4.525 (95% CI 1.372, 7.677), p = 0.005] compared with HC and lower cfPWV (p < 0.001) but similar AIx@75 (p = 0.193) versus DM patients. In the APS group, cfPWV was independently associated with age [β = 0.056 (95% CI 0.034, 0.078), p < 0.001], mean arterial pressure (MAP) [β = 0.070 (95% CI 0.043, 0.097), p < 0.001], atherosclerotic femoral plaques [β = 0.732 (95% CI 0.053, 1.411), p = 0.035] and anti-β2-glycoprotein I IgM positivity [β = 0.696 (95% CI 0.201, 1.191), p = 0.006]. AIx@75 was associated with age [β = 0.334 (95% CI 0.117, 0.551), p = 0.003], female sex [β = 7.447 (95% CI 2.312, 12.581), p = 0.005] and MAP [β = 0.425 (95% CI 0.187, 0.663), p = 0.001].
Conclusion:
APS patients exhibit elevated AIx@75 vs HC and similar to DM patients, indicating enhanced arterial stiffening in APS. Given its prognostic value, ArS evaluation may help to improve cardiovascular risk stratification in APS.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Pulse
The pulse serves as a clinical...
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

